Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Verstraeten

Showing results (21-30 of 78) with videos related to

Pageof 8
Sort By:
Pharmacoepidemiology and Drug Safety|March 3, 2012
Using time-to-onset for detecting safety signals in spontaneous reports of adverse events following immunization: a proof of concept studyLionel Van Holle, Ziad Zeinoun, Vincent Bauchau, et al.
Plos One|March 31, 2018
The incidence of medically-attended norovirus gastro-enteritis in Japan: Modelling using a medical care insurance claims databaseChia-Hsien Chang, Motonobu Sakaguchi, John Weil, et al.
Expert Review of Vaccines|August 7, 2003
Vaccine safety surveillance using large linked databases: opportunities, hazards and proposed guidelinesThomas Verstraeten, Frank DeStefano, Robert T Chen, et al.
The Pediatric Infectious Disease Journal|March 6, 2015
The burden of norovirus disease in children in the European UnionFrank Kowalzik, Margarita Riera-Montes, Thomas Verstraeten, et al.
Plos One|July 21, 2016
Modelling Estimates of Norovirus Disease in Patients with Chronic Medical ConditionsThomas Verstraeten, Baoguo Jiang, John G Weil, et al.
BMC Infectious Diseases|October 16, 2015
A decade of norovirus disease risk among older adults in upper-middle and high income countries: a systematic reviewLisa Lindsay, Joanne Wolter, Ilse De Coster, et al.
Vaccine|May 21, 2011
Pregnancy and safety outcomes in women vaccinated with an AS03-adjuvanted split virion H1N1 (2009) pandemic influenza vaccine during pregnancy: a prospective cohort studyFernanda Tavares, Irwin Nazareth, Javier Sawchik Monegal, et al.
The Pediatric Infectious Disease Journal|December 30, 2021
Economic Evaluation of Universal Varicella Vaccination in MexicoEnrique Chacon-Cruz, Estelle Meroc, Sue Ann Costa-Clemens, et al.
The Journal of Infectious Diseases|September 30, 2017
Estimating the Burden of Medically Attended Norovirus Gastroenteritis: Modeling Linked Primary Care and Hospitalization DatasetsThomas Verstraeten, Tom Cattaert, John Harris, et al.
Human Vaccines|February 18, 2009
Safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for cervical cancer prevention: a pooled analysis of 11 clinical trialsDominique Descamps, Karin Hardt, Bart Spiessens, et al.
Pageof 8

Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
Pharmacoepidemiology and Drug Safety|March 3, 2012
Using time-to-onset for detecting safety signals in spontaneous reports of adverse events following immunization: a proof of concept studyLionel Van Holle, Ziad Zeinoun, Vincent Bauchau, et al.
Plos One|March 31, 2018
The incidence of medically-attended norovirus gastro-enteritis in Japan: Modelling using a medical care insurance claims databaseChia-Hsien Chang, Motonobu Sakaguchi, John Weil, et al.
Expert Review of Vaccines|August 7, 2003
Vaccine safety surveillance using large linked databases: opportunities, hazards and proposed guidelinesThomas Verstraeten, Frank DeStefano, Robert T Chen, et al.
The Pediatric Infectious Disease Journal|March 6, 2015
The burden of norovirus disease in children in the European UnionFrank Kowalzik, Margarita Riera-Montes, Thomas Verstraeten, et al.
Plos One|July 21, 2016
Modelling Estimates of Norovirus Disease in Patients with Chronic Medical ConditionsThomas Verstraeten, Baoguo Jiang, John G Weil, et al.
BMC Infectious Diseases|October 16, 2015
A decade of norovirus disease risk among older adults in upper-middle and high income countries: a systematic reviewLisa Lindsay, Joanne Wolter, Ilse De Coster, et al.
Vaccine|May 21, 2011
Pregnancy and safety outcomes in women vaccinated with an AS03-adjuvanted split virion H1N1 (2009) pandemic influenza vaccine during pregnancy: a prospective cohort studyFernanda Tavares, Irwin Nazareth, Javier Sawchik Monegal, et al.
The Pediatric Infectious Disease Journal|December 30, 2021
Economic Evaluation of Universal Varicella Vaccination in MexicoEnrique Chacon-Cruz, Estelle Meroc, Sue Ann Costa-Clemens, et al.
The Journal of Infectious Diseases|September 30, 2017
Estimating the Burden of Medically Attended Norovirus Gastroenteritis: Modeling Linked Primary Care and Hospitalization DatasetsThomas Verstraeten, Tom Cattaert, John Harris, et al.
Human Vaccines|February 18, 2009
Safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for cervical cancer prevention: a pooled analysis of 11 clinical trialsDominique Descamps, Karin Hardt, Bart Spiessens, et al.
Pageof 8